Outcome and tolerability of topiramate in brain tumor associated epilepsy

Journal of Neuro-Oncology

Volumn 86, Issue 1, 2008, Pages 61-70

  Maschio, M ^a   Dinapoli, L ^a   Zarabla, A ^a   Pompili, A ^a   Carapella, C M ^a   Pace, A ^a   Giannarelli, D ^a   Occhipinti, E ^a   Jandolo, B ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

AEDs; Brain tumors; Epilepsy; Side effects; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHLOROETHYLNITROSOUREA; DOCETAXEL; ETIRACETAM; FLUOROURACIL; FOTEMUSTINE; GABAPENTIN; GEMCITABINE; IRINOTECAN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PROCARBAZINE; TEMOZOLOMIDE; TOPIRAMATE; VALPROIC ACID; VINCRISTINE;

ADD ON THERAPY; ADULT; ARTICLE; BRAIN TUMOR; COGNITIVE DEFECT; COMPLEX PARTIAL SEIZURE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HEMATOLOGICAL PARAMETERS; HUMAN; INCIDENCE; MALE; MENINGIOMA; NEUROSURGERY; OBSERVATIONAL STUDY; PERIARTHRITIS; RASH; SIDE EFFECT; SIMPLE PARTIAL SEIZURE; TONIC CLONIC SEIZURE; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

ADULT; AGED; ANTICONVULSANTS; BRAIN NEOPLASMS; DRUG EVALUATION; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 37249049272     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9430-3     Document Type: Article

References (49)

1. De Angelis L (2001) Brain tumors. N Engl J Med 344:114-123
2. Hwang SL, Lin CL, Lee KS, Lieu AS, Kuo TH, Chang CZ, Yen CP, Lin CK, Loh JK, Huang TY, Howng SL (2004) Factors influencing seizures in adult patients with supratentorial astrocytic tumors. Acta Neurochir 146:589-594
3. Lote K, Stenwig AE, Skullerud K, Hirschberg H (1998) Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer 34(1):98-102
4. Luyken C, Blumcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD, Schramm J (2003) The spectrum of long term epilepsy-associated tumors: Long term seizure and tumor outcome and neurosurgical aspects. Epilepsia 44(6):822-830
5. Mason WP. (2003) Anticonvulsant prophylaxis for patients with brain tumors: Insights from clinical trials. Can J Neurol Sci 30:89-90
6. Hildebrand J (2004) Management of epileptic seizures. Curr Opin Oncol 16:314-317
7. Schaller B, Rüegg SJ (2003) Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia 44(9):1223-1232
8. Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B (1995) The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52:717-724
9. Wen PY, Marks PV (2002) Medical management of patients with brain tumors. Curr Opin Oncol 14(3):299-307
10. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 54:1886-1893
11. Temkin NR (2001) Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: Meta-analysis of controlled trials. Epilepsia 42(4):515-524
12. Vecht CJ, Wagner GL, Wilms EB (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2:404-409
13. Vecht CJ, Wagner GL, Wilms EB (2003) Treating seizures in patients with brain tumors: Drug interactions between antiepileptic and chemotherapeutic agents. Semin Oncol 30(9):49-52
14. Bourgeois Blaise FD (1999) Pharmacokinetics and metabolism of topiramate. Drugs of Today 35(1):43-48
15. Anderson GD (2004) Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology 63(4):S3-S8
16. Bialer M, Doose DR, Murthy B, Curtin C, Wang SS, Twyman RE, Schwabe S (2004) Pharmacokinetic interactions of topiramate. Clin Pharmacokinet 43(12):763-780
17. Nallani SC, Glauser TA, Hariparsad N, Setchell K, Buckley DJ, Buckley AR, Desai PB (2003) Dose-dependent induction of Cytochrome P450 (CYP) 3A4 and Activation of Pregnane X Receptor by Topiramate. Epilepsia 44(12):1521-1528
18. Beghi E. (2004) Efficacy and tolerability of the new antiepileptic drugs: Comparison of two recent guidelines. Lancet Neurol 3:618-621
19. Patsalos PN, Froscher W, Pisani F, Van Rijn CM (2002) The importance of drug interactions in epilepsy therapy. Epilepsia 43(4):365-385
20. Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS (2004) Seizure prophylaxis in patients with brain tumors: A meta-analysis. Mayo Clin Proc 79(12):1489-1494
21. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD. Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA (2004) Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy. Neurology 62:1261-1273
22. Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R (2003) Differential cognitive and behavioural effects of topiramate and valproate. Neurology 60:1483-1488
23. Salinsky MC, Storzbach D, Spencer DC, Oken BS, Landry T, Dodrill CB (2005) Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 64:792-798
24. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189-198
25. Karnofsky DA, Burchenal JH, Armistead GC, Southam CM, Berstein JL, Craver LF, Rhoads CP (1951) Triethylene melamine in the treatment of neoplastic disease. Arch Int Med 87:477-516
26. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events v3.0, DCTD, NCI, NIH, DHHS, December 12, 2003 (http://ctep.cancer.gov)
27. Brada M, Viviers L, Hines F, Britton J, Ashley S, Sardell S, Traish D, Gonsalves A, Wilkins P, Westbury C (2003) Phase II of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715-1721
28. Prados MD, Scott C, Curran WJ Jr, Nelson DF, Leibel S, Kramer S (1999) Procarbazine, lomustine and vincristine (PCV) chemotherapy for anaplastic astrocytoma. A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J Clin Oncol 17:3389-3395
29. Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
30. Fadul CE, Meyer LP, Jobst BC, Cornell CJ, Lewis LD (2002) Agranulocytosis Associated with Lamotrigine in a Patient with Low-grade Glioma. Epilepsia 43(2):199-200
31. Hildebrand J, Lecaille C, Perennes J, Delattre J-Y (2005) Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 65:212-215
32. Ieiri I, Morioka T, Kim S, Nishio S, Fukui M, Higuchi S (1996) Pharmacokinetic study of zonisamide in patients undergoing brain surgery. J Pharm Pharmacol 48(12):1270-1275
33. Khan RB, Hunt DL, Thompson SJ (2004) Gabapentin to control seizures in children undergoing cancer treatment. J Child Neurol 19(2):97-101
34. Maschio M, Albani F, Baruzzi A, Zarabla A, Dinapoli L, Pace A, Pompili A, Carapella CM, Occhipinti E, Jandolo B (2006) Levetiracetam therapy in patients with brain tumor and epilepsy. J Neurooncol 80(1):97-100
35. Mauro AM, Bomprezzi C, Morresi S, Provinciali L, Formica F, Iacoangeli M, Scerrati M (2007) Prevention of early postoperative seizures in patients with primary brain tumors: Preliminary experience with oxcarbazepine. J Neurooncol 81(3):279-285
36. Newton HB, Goldlust SA, Pearl D (2005) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78(1):99-102
37. Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 75:255-260
38. Perry JR, Sawka C (1996) Add-on Gabapentin for refractory seizures in patients with brain tumors. Can J Neurol Sci 23:128-131
39. Striano S, Striano P, Boccella P, Noverino C, Bilo L (2002) Tiagabine in glial tumors. Epilepsy Res 49:81-85
40. Wagner GL, Wilms EB, Van Donselaar CA, Vecht CJ (2003) Levetiracetam: preliminary experience in patients with primary brain tumors. Seizure 12:585-586
41. Guerrini R, Parmeggiani L (2006) Topiramate in its clinical applications in epilepsy. Expert Opin Pharmacother 7(6):811-823
42. Guerrini R, Carpay H, Groelj J, Van Oene J, Lahaye M, Schwalen S (2005) Top-Int-51 Investigator's group. Topiramate monotherapy as broad spectrum antiepileptic in naturalistic clinical setting. Seizure 14:371-380
43. Pace A, Vidiri A, Galiè E, Carosi M, Telera S, Cianciulli AM, Canalini P, Giannarelli D, Jandolo B, Carapella CM (2003) Temozolomide chemotherapy for progressive low-grade glioma: Clinical benefits and radiological response. Ann Oncol 14:1722-1726
44. Rogers LR, Morris HH, Lupica K (1993) Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy. Neurology 43(8):1599-1601
45. Smith DF, Hutton JL, Sandemann D, Foy PM, Shaw MD, Williams IR, Chadwick DW (1991) The prognosis of primary intracerebral tumors presenting with epilepsy: The outcome of medical and surgical management. J Neurol Neurosurg Psychiatry 54(10):915-920
46. Warnke PC, Berlis A, Weyerbrock A, Ostertag CB (1997) Significant reduction of seizure incidence and increase of benzodiazepine receptor density after interstitial radiosurgery in low-grade gliomas. Acta Neurochir Suppl 68:90-92
47. Taylor LP, Posner JB (1989) Phenobarbital rheumatism in patients with brain tumor. Ann Neurol 25(1):92-94
48. Arvio M, Sillanpää M (2005) Topiramate in long-term treatment of epilepsy in the intellectually disabled. J Intell Dis Res 49:183-189
49. Singh BK, White-Scott S (2002) Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities. Seizure 11:47-50